Skip to content

Echo Jq-5C-R

by Hi-Dow International Inc.

Echo Jq-5C-R is a medical device (FDA Class II) made by Hi-Dow International Inc., cleared under FDA 510(k) K102598 on 13 May 2011 and listed in FDA GUDID since 13 Jun 2017 (UDI-DI 00851640007320), active as of 22 Oct 2026.

Active United States. Also listed in GUDID (US).

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None found

in data synced 22 Oct 2026

Documents

510(k) K102598

FDA submission, from GUDID

Trust

Unverified

Source GUDID, synced 22 Oct 2026.

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesGUDID listing Number00851640007320 UDI-DI Date13 Jun 2017ListedStatusListed GUDID: in commercial distribution
United StatesFDA 510(k)SESE from GUDID Substantially Equivalent · Traditional NumberK102598 Date13 May 2011DecidedStatusActive

Official records

Across registries

2 registries list this device

  • FDA 510(k) K102598 decided 13 May 2011 Active
  • FDA GUDID UDI-DI 00851640007320 listed 13 Jun 2017 Listed

Timeline

2 dated events

  1. Cleared FDA 510(k) K102598
  2. Listed FDA GUDID 00851640007320

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

GUDID

Trade name
Echo
Generic name
Physical therapy transcutaneous neuromuscular electrical stimulation system
Model / reference
JQ-5C-R
Primary DI / UDI-DI
00851640007320
510(k) Number
FDA product code
NUH, NGX
GMDN term
Physical therapy transcutaneous neuromuscular electrical stimulation system
Device class
Class II
Regulation number
882.5890, 890.5850
GUDID distribution status
In Commercial Distribution

Similar devices

Other devices filed under FDA product code NUH (Stimulator, Nerve, Transcutaneous, Over-The-Counter).

Other devices from Hi-Dow International Inc.

See all devices from Hi-Dow International Inc. →

Properties

  • Serial number
  • Manufacturing date
Other properties (13, all answered No)